<DOC>
	<DOCNO>NCT03072550</DOCNO>
	<brief_summary>Early feasibility study determine three-treatment protocol RenewalNail™ plasma treatment system week result mycological cure and/or clear nail growth treat hallux toe .</brief_summary>
	<brief_title>Early Feasibility Study Evaluate Efficacy Safety RenewalNail™ Plasma Treatment System Patients With Mild Moderate Onychomycosis ( Fungal Nail )</brief_title>
	<detailed_description>The Sponsor develop RenewalNail™ plasma treatment system topically treat fungal infect toenail . The goal RenewalNail™ therapy overcome shortcoming topical oral therapy combine safety topical treatment efficacy oral treatment . The primary objective early feasibility study evaluate efficacy safety RenewalNail™ plasma treatment system Protocol achieve mycological cure patient . The Protocol call three 45-minute treatment perform week achieve mycological cure . Mycological cure assess two consecutive mycological culture test do week . Two consecutive negative result confirm elimination fungus cause onychomycosis infection , recommend recent FDA guidance . There placebo arm study . Secondary objective include assess treatment protocol result clear nail growth patient 5-month interval .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Subjects 21 75 year ( inclusive ) age ; Subjects male female race ; Subjects good general health free clinically significant disease might interfere study evaluation . Subjects establish clinical diagnosis distal subungual onychomycosis ; Subjects least one big toe nail involve 2075 % infection ; Subjects positive KOH culture onychomycosis dermatophytes screen nail sample ; Subjects whose infection confirm caused T. rubrum T. mentagrophytes ; Subjects willing able refrain employing ( nonstudy ) treatment ( traditional alternative ) toenail onychomycosis throughout study participation ; Subjects willing able refrain use nail cosmetic clear and/or color nail lacquer throughout study participation ; Subjects willing able give write informed consent able adhere procedure visit schedule ; Women childbearing potential currently sexually active must agree use medically accept method contraception receive protocol specify treatment . Methods include condom ( male female ) without spermicidal agent , diaphragm cervical cap spermicide , medically prescribe intrauterine device , oral systemic hormonal contraceptive ( plus additional reliable barrier method ) , surgical sterilization ( e.g. , hysterectomy tubal ligation ) ; Women childbearing potential currently sexually active must agree use medically accept method contraception become sexually active participate study ; Women childbearing potential must negative pregnancy test prior start study . Subjects presence dermatophytoma ( define demarcate localized thick mass ) fungal hyphae necrotic keratin nail plate nail bed ) target nail ; Subjects onychomycosis infection involve lunula affect toenail ( ) spike disease extend nail matrix affect big toenail ( ) ; Subjects condition distal subungual onychomycosis know cause abnormal nail appearance psoriasis , severe moccasintype tinea pedis require treatment , symptomatic interdigital tinea pedis , lichen planus , abnormality could result clinically abnormal nail ; Subjects whose foot large ( large US men 's size 13 ) small ( small US woman 's size 3 ) properly fit plasma treatment device ; Subjects history multiple repeat failure previous therapy onychomycosis ; Subjects whose affected big toenail become normal opinion investigator ; Subjects abnormality affect big toenail ( ) could prevent normal appear nail clearing infection achieve ; Subjects trauma affect big toenail ( ) identify study doctor ; Subjects receive topical antifungal treatment nail within 2 week study initiation ; Subjects receive systemic antifungal treatment within 3 month study initiation ; Subjects dementia psychic condition might interfere ability understand study thus give write informed consent ; Simultaneous participation another clinical study participation another clinical study 30 day directly precede treatment ; Subjects unwilling unable refrain employing ( nonstudy ) treatment ( traditional alternative ) toenail onychomycosis throughout study participation ; Subjects unwilling unable refrain use nail cosmetic clear and/or color nail lacquer end study participation ; Subjects immunocompromised ( e.g . adrenal insufficiency , diabetes mellitus , febrile neutropenia , human immunodeficiency virus infect ) ; Subjects underwent treatment type cancer within last six month ; Subjects pacemaker , metallic implant prostheses vicinity treatment site ( ankle , foot , etc . ) ; Subjects clinically significant condition situation , condition study , opinion investigator , would interfere study evaluation optimal participation study ; Subjects may unreliable study include Subjects engage excessive alcohol intake drug abuse ( test require ) , Subjects unable return schedule followup visit ; Subjects feel sit 45 minute time treatment . Subjects part staff personnel directly involve study ; Subjects family member investigational study staff ; Subjects history sign peripheral circulatory insufficiency and/or diabetic neuropathy ; Subjects know allergy test treatment product [ i.e . perfluorocarbon plastic polycarbonate ] ; Women pregnant , breastfeeding , plan pregnancy prior end study participation ;</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>fungal nail</keyword>
	<keyword>toenail fungus</keyword>
</DOC>